Fig. 2From: B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patientsOverall survival (OS) analysis of patients with MIBC based on B4GALT1 expression. Kaplan-Meier analysis of OS in training cohort (n = 142) (left) and in validation cohort (n = 112) (right). P value was calculated by log-rank testBack to article page